Australia's Microba Life Sciences rises on Midnight Health partnership

Microba Life Sciences

26/05/2022 02:23

** Shares of Microba Life Sciences  MAP.AX  rise as much as
6% to A$0.265, set for best session since May 16 if gains hold 
    ** Co signs https://www.asx.com.au/asxpdf/20220526/pdf/459bdnqgdl5jf6.pdf
 strategic partnership agreement with Midnight Health, a digital
healthcare co backed by nib Holdings  NHF.AX  
    ** Under agreement, Midnight Health will promote, market and
sell a new subscription consumer health service driven by
Microba's core technology - MAP
    ** Stock has fallen ~28.6% since its IPO in early April

 (Reporting by Upasana Singh in Bengaluru)
 ((Upasana.Singh@thomsonreuters.com))